Pharmalenic is a specialty company focused on the research, development and manufacturing expertise in the production of advanced lipid-based nanoparticles for transdermal delivery systems, to clients and partners in both the academic and industrial sectors like pharmaceutical, biotechnology and medical devices sectors.
Our delivery systems can be designed to:
Release their contents when they reach a specific temperature.
Release their contents at a specific pH value.
Target certain tissues or cell types by changing the types of lipids in the encapsulation.
Target tissues, cell types or specific proteins by attaching antibodies to the surface.
Avoid certain tissues or cells by attaching complex sugars to the surface.
Evenly distribute fat-soluble (oil-like) compounds such as certain vitamins, antioxidants, antibiotics, flavors, etc. which often can’t be mixed in water-based products including most foods.
Fuse with cells, which is important in delivering DNA to a cell.
Serve as model cell membranes making it easier to study specific cellular processes and how certain molecules, such as drugs, interact with cells.
Protect compounds from acidic and enzymatic degradation in the stomach and intestine by using certain molecules to coat the encapsualation.
Protect compounds such as vitamins and antioxidants from premature oxidation for increased shelf-life.
Enhance the intestinal absorption of compounds by coating with certain molecules.
Carry drugs across the nasal mucosa (nasal drug delivery).
Deliver drugs directly to lung tissue by inhalation of the nanosome.
Carry fluorescent dyes or other types of molecules which allow the nanosomes to be tracked in the system to which they are added.
Some of the on-going collaborative projects are:
1) Development of new type of nanoencapsulation to transdermal delivery systems.
2) Research on novel nanocarrier to DNA delivery.
3) Development of sub-micron nanoparticles for application in cosmetics.
© 2020 Pharmalenic Laboratories. All rights reserved